Showing results (1461-1470 of 2,021) with videos related to
Sort By:
Pageof 203
Annals of Hepatology|June 8, 2024
The steatosis-associated fibrosis estimator (SAFE) outperformed the FIB-4 score in screening the population for liver diseaseMingkai Li, Ying Lin, Hongsheng Yu, et al.Annals of Hepatology|January 19, 2026
Roles of zinc in the gut-liver axisKurt Grüngreiff, Dirk Reinhold, Wolfgang MaretAnnals of Hepatology|January 21, 2026
Clinical, etiological, and demographic aspects of cirrhosis in South America: a report from the South American Liver Research NetworkJhon E Prieto, Diego R Puentes, Angelo-Z Mattos, et al.Annals of Hepatology|January 17, 2026
Clostridium butyricum reduces the incidence of overt hepatic encephalopathy in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt (TIPS)Xiaotong Xu, Tong Zhu, Changyou Jing, et al.Annals of Hepatology|November 29, 2025
Natural history and outcomes of MASLD and MetALD following non-alcoholic fatty liver disease reclassification in a Canadian cohortYousef Almahanna, Francisco Idalsoaga, Luis Antonio Díaz, et al.Annals of Hepatology|November 28, 2025
Early-life exposure to tobacco smoke and chronic liver disease incidence in adulthoodXiaoqin Xu, Jiang Li, Yanqi Fu, et al.Annals of Hepatology|February 10, 2025
Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK)Zobair M Younossi, James M Paik, Linda Henry, et al.Annals of Hepatology|January 5, 2025
The promoting effect of the POU3F2/METTL16/PFKM cascade on glycolysis and tumorigenesis of hepatocellular carcinomaMing Chen, Yuan Yang, Guangsheng Hu, et al.Annals of Hepatology|December 14, 2024
An exploratory machine learning model for predicting advanced liver fibrosis in autoimmune hepatitis patients: A preliminary studyQinglin Wei, Wen Li, Shubei He, et al.Annals of Hepatology|December 9, 2024
Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experienceThanikan Sukaram, Soe Thiha Maung, Yuda Chongpison, et al.Pageof 203